RX-LINQ
DEAD

Serial Number

97561880

Owner

Ringmaster Technologies, Inc.

Attorney

Darren M. Geliebter

Filing Date

Aug 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

RX-LINQ Trademark

Serial Number: 97561880

RX-LINQ is a trademark filed by Ringmaster Technologies, Inc. on August 24, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Ringmaster Technologies, Inc. (22 trademarks)

Boonton, NJ 07005

Entity Type: 03

Trademark Details

Filing Date

August 24, 2022

Registration Date

Not Registered

Goods & Services

Cloud-based platform as a service featuring computer software platforms that use pharmacy data to provide end-to-end business management tools and solutions for pharmacies, pharmacy consultants, brokers, and third party administrators, namely, managing, using, storing, and analyzing pharmacy data for the purposes of streamlining, managing, implementing, standardizing, reconciling, auditing, and marketing pharmacy benefit management contracts, pharmacy benefit management programs, and requests for proposals pertaining to pharmacy benefit claims; Cloud-based platform as a service featuring computer software platforms that store pharmaceutical insurance benefits claims data, generate reports based on pharmaceutical insurance benefits claims data, provide data analytics based on pharmaceutical insurance benefits claims data, implement contract reconciliations based on pharmacy insurance benefits claims and claims data, and provide audits on user performance; Cloud-based platform as a service featuring computer software platforms for use by pharmacies, pharmacy consultants, employer-sponsored health plan pharmacy consultants, brokers, third-party administrators, pharmacy benefit managers, health management organizations, employer-sponsored health plans, therapeutic counselors, formulary managers, and data analytics providers for the procurement of pharmacy benefit management contracts, pharmacy benefit management programs, and requests for proposals pertaining to pharmacy benefits claims

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 15, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 15, 2026 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 15, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 15, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 15, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2024 CRFA
ASSIGNED TO LIE
Jul 3, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 9, 2024 TROA
NOTICE OF REVIVAL - E-MAILED
Jan 9, 2024 NREV
NOTICE OF REVIVAL - E-MAILED
Jan 9, 2024 NREV
PETITION TO REVIVE-GRANTED
Jan 9, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 9, 2024 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 13, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 9, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 9, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 26, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 12, 2022 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 12, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 8, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 13, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2022 NWOS
NEW APPLICATION ENTERED
Aug 27, 2022 NWAP